← FDA Drug Approvals (Drugs@FDA)

NESINA

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2013-01-25

Drug application

FDA Application #

NDA022271

Application type

New Drug Application

Brand name

NESINA

Generic name

ALOGLIPTIN

Active ingredients

ALOGLIPTIN BENZOATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Padagis Israel Pharmaceuticals Ltd

First approval

2013-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown